In this article by Liang Yao and colleagues (BMJ 2023;383:e076226, doi:10.1136/bmj-2023-076226, published 15 December 2023), errors in fig […]
SARON trial shows 56% improvement over standard treatment
MAD World Summit 2026 has secured official accreditation from The CPD Group
In April the United Nations, European Union, and World Bank published their Final Rapid Damage and Needs Assessment […]
Clark discusses The BMJ’s AI policy.1 I think academic publishing is in a deep crisis. Virtually any neural […]
Tens of thousands of young people in England have been waiting more than a year for an NHS […]
Early responses suggest restored sensitivity to anti‑PD‑1 therapy
First-in-class therapy offers functional cure potential
A surprising discovery reveals that widely used anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body. […]
